Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129718) titled 'First-in-Man Study of the Broadband Synergistic Pulsed Ablation System for the Treatment of Thyroid Nodules' on Aug. 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Thyroid Tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2023-11-01
Target Sample Size: Experimental Group:6;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=321200
Published by HT Digital Content Services with permission from Health Daily Digest....